Gene therapy for choroideremia continues to improve some patients’ vision 3.5 years after treatment. Medscape Medical News
Tag: Ophthalmology
Many With Wet AMD Need Ranibizumab Retreatment Even After Year-Long Pause
Retreatment with ranibizumab is necessary for up to a third of neovascular age-related macular degeneration (AMD) patients who are treatment-free for one year, new research shows. Reuters Health Information
Visual Field Needed for Driving Eligibility Preserved After Laser Panretinal Photocoagulation
Multispot laser panretinal photocoagulation (PRP) in proliferative diabetic retinopathy spares visual fields required for driving eligibility, researchers report. Reuters Health Information
Office-Based Cataract Surgery Safe and Effective
In-office cataract surgery provided patient outcomes comparable to hospital-based procedures while minimizing direct medical costs, a large, population-based study has found. Medscape Medical News
Is Weight Gain to Blame for This Man’s Blurred Vision?
A 42-year-old man presents with blurred vision of gradual onset in his left eye. A closer look at his history may provide the clues to the diagnosis. Medscape Ophthalmology
Reaching a Milestone in the Treatment of Keratoconus
The recent approval of corneal crosslinking by the FDA is an important step forward in the treatment of keratoconus. Dr Roger Steinert offers commentary. Medscape Ophthalmology
Open-Angle Glaucoma Treated With MicroPulse Laser
How does MicroPulse laser trabeculoplasty compare with argon laser trabeculoplasty and selective laser trabeculoplasty in the treatment of open-angle glaucoma? Medscape Ophthalmology
FDA Approves Photrexa for Corneal Crosslinking in Keratoconus
The riboflavin ophthalmic solution, once irradiated with ultraviolet A light, treats sight-threatening keratoconus with corneal collagen crosslinking. FDA Approvals
AMD Risk Higher Among Outdoor Workers
AMD risk was significantly higher in those who had worked outside or spent long hours in the sun earlier in life; current sun exposure did not affect risk, however. Medscape Medical News
AMD: Untreated Sleep Apnea May Reduce Response to Bevacizumab
A small, single-center study has suggested untreated sleep apnea reduces treatment response to bevacizumab in patients with exudative age-related macular degeneration. Medscape Medical News
Combined Surgery for Refractory Glaucoma and Cataract
Is this combined procedure a safe and effective alternative treatment option for refractory glaucoma? Journal of Glaucoma
Nagging Questions About Government Plans for Ophthalmology
It isn’t the GOP or Democratic primary candidates’ proposals for reining in the cost of healthcare that concern ophthalmologists — it’s Medicare’s. Medscape Business of Medicine
Low Vitamin D Levels Linked to Macular Degeneration Risk
Adults with the lowest levels of circulating vitamin D levels had the highest risk for age-related macular degeneration, particularly late-stage, compared with those with the highest levels. Medscape Medical News
Modifiable Risk Factors for AMD: The Role of Statins
If cardiovascular disease and age-related macular degeneration (AMD) share some pathophysiologic mechanisms, would interventions that reduce cardiovascular disease help reduce the progression of AMD? Medscape Ophthalmology
Modifiable Risk Factors for AMD
If cardiovascular disease and age-related macular degeneration (AMD) share some pathophysiologic mechanisms, would interventions that reduce cardiovascular disease help reduce the progression of AMD? Medscape Ophthalmology
Corneal Graft Success Over 30 Years
Dr Christopher Rapuano reviews surprising and questionable corneal graft survival rates between two surgical techniques. Medscape Ophthalmology
Innovations and Adaptations in Trabeculectomy
This new review gives us an overview of the latest updates in trabeculectomy, and discusses its current role in the management of glaucoma. Current Opinion in Ophthalmology
Retina Implant’s Higher Resolution Alpha AMS Visual Implant Cleared in EU
Retina Implant AG, a Reutlingen, Germany firm, obtained European regulatory approval for its Alpha AMS subretinal implant for people that have become blind due to retinitis pigmentosa. The new device is an upgrade to the Alpha IMS that was cleared in Europe back in 2013. The Alpha AMS features 1,600 pixels, which is 100 more than […]
Dexamethasone Implant Helps Some With Diabetic Macular Edema
An intravitreal dexamethasone implant (Ozurdex, Allergan) can prompt improvement in patients with diabetic macular edema refractory to multiple anti-vascular endothelial growth factor (anti-VEGF) injections, according to Korean researchers. Reuters H…
Dexamethasone Implant in DME in Real-Life Situations
Are intravitreal dexamethasone implants a safe and effective treatment option for diabetic macular edema? New data from real-life experience sheds some light. Eye